A stock analyst has uncovered information suggesting that a recently withdrawn multiple sclerosis drug suppresses the immune system.
It sure doesn't seem like it would be necessary to file a FOIA request to learn that Tysabri suppresses the immune system. Unless this intrepid stock analyst learned some details about this suppression, I'm not sure why this is news. If the stock analyst did learn details, then let's have 'em.
technorati tags: multiple sclerosis, tysabri